All AbMole products are for research use only, cannot be used for human consumption.
Tauroursodeoxycholic acid (TUDCA) is an ambiphilic bile acid. TUDCA is the taurine conjugate form of ursodeoxycholic acid (UDCA). TUDCA has been used in ancient Asian pharmacopoeias for its supposed beneficial effects. Ongoing research is finding TUDCA has diminishing apoptotic effects, helping with cardiac function, Huntington's disease, Parkinson's Disease, and stroke.
J Ethnopharmacol. 2022 October 5;296:115519.
Lycium barbarum L. and Salvia miltiorrhiza Bunge protect retinal pigment epithelial cells through endoplasmic reticulum stress
Tauroursodeoxycholic acid (Ursodoxicoltaurine) purchased from AbMole
Biomed Pharmacother. 2018 Jul 20;106:1271-1281.
Tauroursodeoxycholic acid alleviates hepatic ischemia reperfusion injury by suppressing the function of Kupffer cells in mice.
Tauroursodeoxycholic acid (Ursodoxicoltaurine) purchased from AbMole
 |
Source | Biomedicine & Pharmacotherapy (2018). Figure 7. TUDCA (AbMole BioScience Ltd.) |
| Method | injected intraperitoneally | |
| Cell Lines | mice | |
| Concentrations | 400 mg/kg | |
| Incubation Time | 3 d | |
| Results | Following treatment with TUDCA, the levels of all the proinflammatory cytokines were significantly decreased. |
 |
Source | Biomedicine & Pharmacotherapy (2018). Figure 6. TUDCA (AbMole BioScience Ltd.) |
| Method | injected intraperitoneally | |
| Cell Lines | mice | |
| Concentrations | 400 mg/kg | |
| Incubation Time | 3 d | |
| Results | In contrast, following treatment with TUDCA, few TUNEL positive hepatic cells were observed compared with those in the I/R group |
 |
Source | Biomedicine & Pharmacotherapy (2018). Figure 5. TUDCA (AbMole BioScience Ltd.) |
| Method | injected intraperitoneally | |
| Cell Lines | mice | |
| Concentrations | 400 mg/kg | |
| Incubation Time | 3 h, 6 h, and 24 h | |
| Results | However, following treatment with TUDCA, all the above mentioned markers were significantly decreased in the I/R + TUDCA group |
 |
Source | Biomedicine & Pharmacotherapy (2018). Figure 4. TUDCA (AbMole BioScience Ltd.) |
| Method | cell viability assay | |
| Cell Lines | KCs | |
| Concentrations | 25 μM | |
| Incubation Time | 96 h | |
| Results | These results demonstrated that TUDCA effectively alleviates the apoptosis of AML cells. |
 |
Source | Biomedicine & Pharmacotherapy (2018). Figure 3. TUDCA (AbMole BioScience Ltd.) |
| Method | immunofluorescence staining | |
| Cell Lines | KCs | |
| Concentrations | 25 uM | |
| Incubation Time | 24 h | |
| Results | The results of immunofluorescence staining showed that, following treatment with an increased concentration of TUDCA, the intensity of fluorescence in the nucleus of KCs was significantly decreased. |
 |
Source | Biomedicine & Pharmacotherapy (2018). Figure 2. TUDCA (AbMole BioScience Ltd.) |
| Method | RT-PCR | |
| Cell Lines | KCs | |
| Concentrations | 0 μM, 25 μM, 50 μM, and 100 μM | |
| Incubation Time | 24 h | |
| Results | Moreover, following treatment with different concentrations of TUDCA, the level of the abovementioned proinflammatory cytokines presented a dose-dependent decrease |
 |
Source | Biomedicine & Pharmacotherapy (2018). Figure 1. TUDCA (AbMole BioScience Ltd.) |
| Method | cell viability assay | |
| Cell Lines | KCs | |
| Concentrations | 0 μM, 25 μM, 50 μM, and 100 μM | |
| Incubation Time | 96 h | |
| Results | The effects of different concentrations of TUDCA on the cell viability of KCs were determined by the MTT assay |
| Molecular Weight | 499.7 |
| Formula | C26H45NO6S |
| CAS Number | 14605-22-2 |
| Solubility (25°C) | DMSO 20 mg/mL Water 10 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related ERK Products |
|---|
| SCH772984
SCH772984 is a novel and selective inhibitor of ERK1/2 with IC50 of 4 nM and 1 nM, respectively. |
| FR 180204
FR 180204 is an ATP-competitive, selective ERK inhibitor with Ki of 0.31 μM and 0.14 μM for ERK1 And ERK2, respectively. |
| GDC-0994
Ravoxertinib (GDC-0994) is an orally active ERK kinase inhibitor with IC50 of 6.1 nM and 3.1 nM against ERK1 and ERK2, respectively. |
| Astragaloside IV
Astragaloside IV is a bioactive saponin first isolated from the dried plant roots of the genus Astragalus, which is used in traditional Chinese medicine. It has various effect on the cardiovascular, immune, digestive, and nervous systems. |
| Corynoxeine
Corynoxeine, isolated from the hook of Uncaria Rhynchophylla, is a potent ERK1/ERK 2 inhibitor in the proliferation of PDGF-BB induced vascular smooth muscle cells (VSMCs). |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
